Monoclonal Antibody from Vir and GSK is 85 Percent Effective | 2021-03-11 | FDAnews

Retrieved on: 2021-03-12 18:12:40

Tags for this article:

Click the tags to see associated articles and topics

Monoclonal Antibody from Vir and GSK is 85 Percent Effective | 2021-03-11 | FDAnews. View article details on hiswai:

Excerpt

Vir Biotechnology and GlaxoSmithKline's monoclonal antibody for COVID-19 reduced hospitalizations or death from the infection by 85 percent in a ...

Article found on: www.fdanews.com